Rossari Biotech Ltd. - ROSSARI, 543213 corporate action history

Rossari Biotech Ltd. NSE: ROSSARI | BSE: 543213

Slowing Down Stock

Download real time

680.55 1.80 (0.27%)

30.03% Fall from 52W High

8,701

NSE+BSE Volume

NSE 27 Jun, 2025 10:06 AM (IST)

Rossari Biotech Ltd. Bonus history

Rossari Biotech Ltd. has not announced any bonus since Jan 1, 2000.

See all forthcoming Bonus and Splits

Rossari Biotech Ltd. Split history

Rossari Biotech Ltd. has not split the face value of the share since Jan 1, 2000.

See all forthcoming Bonus and Splits

Dividend history for Rossari Biotech Ltd.

Rossari Biotech Ltd. has declared 5 dividends since Sept. 8, 2021.

In the past 12 months, Rossari Biotech Ltd. has declared an equity dividend amounting to ₹1.00 per share.

At the current share price of ₹680.5500, Rossari Biotech Ltd.'s dividend yield is 0.15%.

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
20 Jun 2025	0.50	FINAL	20 Jun 2025	Equity Share
16 Aug 2024	0.50	FINAL	-	Equity Share
24 May 2023	0.50	FINAL	-	Equity Share
07 Jul 2022	0.50	FINAL	-	Equity Share
08 Sep 2021	0.50	FINAL	-	Equity Share

See all forthcoming dividends Check out stocks with top dividend.

Board Meetings - Rossari Biotech Ltd.

The latest board meeting for Rossari Biotech Ltd. took place on 25 Apr 2025, for the purpose of Audited Results & Final Dividend

Ex-Date	Purpose	Notes
25 Apr 2025	Audited Results & Final Dividend	-
21 Jan 2025	Quarterly Results	-
19 Oct 2024	Quarterly Results	-
20 Jul 2024	Quarterly Results	-
29 Apr 2024	Audited Results & Final Dividend	-
20 Jan 2024	Quarterly Results	-
21 Oct 2023	Quarterly Results	-
29 Jul 2023	Quarterly Results	-
29 Apr 2023	Audited Results & Final Dividend	-
04 Feb 2023	Quarterly Results	-

See all Board Meetings for Rossari Biotech Ltd.

Rossari Biotech Ltd. Rights history

Rossari Biotech Ltd. has not issued any rights since Jan 1, 2000.

See all Rights History for Rossari Biotech Ltd.

VOTE: Is Rossari Biotech Ltd. worth buying?

67 Votes:

Buy 91.04%

Sell 2.99%

Hold 5.97%

RESEARCH REPORTS

Buy SEE REPORTS >

Buy SEE REPORTS >